Abstract:Objective To summarize the clinical manifestations, imaging characteristics and experience of surgical treatment of spinal cord terminal syringomyelia with tethered cord syndrome (TCS). Methods and Results Clinical data of 10 patients with spinal cord syringomyelia combined with TCS surgically treated under microscope from January 1999 to March 2014 in our hospital were retrospectively analyzed. There were 3 males and 7 females with average age of 15.06 years old (ranged from 2 to 35 years old). The course of disease ranged from 3 months to 20 years (average 42.17 months). Among those patients, one patient presented hydromyelia, 8 patients suffered from meningeal cyst within the sacral canal, and one patient were concurrent with sacral dermal sinus. The weakness of lower extremities, especially distal limbs, was the main clinical manifestation. Five patients were accompanied with bowel and bladder dysfunction and 5 patients with sensory disturbance below the level of syringomyelia, especially hypesthesia. Preoperative MRI showed conus medullaris disappeared at the end of spinal cord, and there was fluid signal in the lower spinal cord with hypo-intensity signal in T1WI and hyper-intensity signal in T2WI without enhancement. All patients underwent surgical procedures. Under microscope, filum terminale was cut off, drainage was performed, meningeal cyst within the sacral canal was removed, and tethered cord was released. The success rate of operations was 100%. The duration of surgery ranged from 1.52 to 3.07 h (average 2.15 h), with average intraoperative blood loss 220 ml (ranged from 100 to 410 ml). The tethering filum had been totally resected and histological examination showed typical filum tissue in all cases. No operative complication was found. Visual Analogue Scale (VAS) score was decreased, and the lower limbs weakness as well as bowel and bladder dysfunction was gradually relieved after operation. The period of follow-up was ranged from 6 months to 14.50 years (average 6.10 years). All patients presented neurological intactness (McCormick gradeⅠ), recovery of conus medullaris, rising of the end of spinal cord, no recurrence of syringomyelia with favorable alignment of spine during follow- up period. Conclusions Terminal syringomyelia in the spinal cord with TCS is rarely occurred and characterized by chronic dysfunction of spinal cord and nerve. The manifestation in MRI imaging is characterized by low level of spinal cord, disappearing of conus medullaris, long T1 and long T2 signal of filum terminale and spinal cord, and no enhancement of capsule wall. The surgical treatment includes resection of filum terminale, drainage of the cerebrospinal fluid (CSF) in syringomyelia, and de-tethering of the spinal cord under microscope. The outcome is satisfactory. DOI: 10.3969/j.issn.1672-6731.2016.03.006

Treatment of syringomyelia using uncultured umbilical cord mesenchymal stem cells: A case report and review of literature

Treatment of Syringomyelia Characterized by Focal Dilatation of the Central Canal Using Mesenchymal Stem Cells and Neural Stem Cells

Surgery for Posttraumatic Syringomyelia： a Retrospective Study of Seven Patients

Umbilical cord-derived mesenchymal stem cell therapy for neurological disorders via inhibition of mitogen-activated protein kinase pathway-mediated apoptosis.

Syringobulbia in Patients with Chiari Malformation Type I: A Systematic Review

Recovery from Bell's palsy after treatment using uncultured umbilical cord-derived mesenchymal stem cells: A case report

Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case report

Umbilical cord-derived mesenchymal stem cells implantation on Hemivertebra defect with three-year follow-up: Biological approach in congenital scoliosis treatment - A case report

Treatment of spinal cord injury with mesenchymal stem cells

Clinical analysis of umbilical cord mesenchymal stem cells in treatment of spinal cord injury

A case series on safety and tolerability of human umbilical cord-derived mesenchymal stem cells on patients in Malaysia

Progress of Human Umbilical Cord Mesenchymal Stem Cell Transplantation for Spinal Cord Injury

Optimizing Therapeutic Strategies for Syringomyelia Associated with Tethered Cord Syndrome: A Comprehensive Review

Percutaneous laser disc decompression combined with secretome of umbilical cord-derived mesenchymal stem cells in a patient with spinal cord injury: A case report

Long-Term Clinical O bservation of Umbilical Cord Mesenchymal Stem Cells in Treating Spinal Cord Injury by Intrathecal Injection

Therapeutic Potential of Umbilical Cord Mesenchymal Stromal Cells Transplantation for Cerebral Palsy: A Case Report

Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury

Functional recovery of a 41-year-old quadriplegic spinal cord injury patient following multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells: a case report

Vertebral body defects treated with umbilical-cord mesenchymal stem cells combined with hydroxyapatite scaffolds: The first case report

Diagnosis and Surgical Treatment of Terminal Syringomyelia Within Spinal Cord Combined with Tethered Cord Syndrome

Abstract 16: Tissue Engineering Approach Using Heterogeneous Hydrogel Combined with Umbilical Cord Derived Multipotent Stem Cells for the Consequences Military Spinal Cord Injury Neurosurgical Treatment (Case Report)